NCT02038335View on ClinicalTrials.gov

HIV-Target Cell Response in Women Initiating Various Contraceptive Methods in High HIV-Incidence Areas: Zim CHIC

CompletedOBSERVATIONAL
Enrollment

451

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

December 31, 2020

Conditions
ContraceptionHIVImmune Cells (Mucosal and Systemic)Microbiota
Interventions
DRUG

DMPA

Depot medroxyprogesterone acetate

DRUG

NET-EN

Norethisterone enantate

DRUG

MPA/E2

Medroxyprogesterone acetate and estradiol cypionate

DEVICE

LNG-I

Levonorgestrel subdermal implant

DEVICE

ENG-I

Etonogestrel subdermal implant

DEVICE

Cu-IUD

Copper IUD

Trial Locations (1)

Unknown

UZ UCSF, Harare

All Listed Sponsors
collaborator

University of Zimbabwe

OTHER

lead

University of Pittsburgh

OTHER

NCT02038335 - HIV-Target Cell Response in Women Initiating Various Contraceptive Methods in High HIV-Incidence Areas: Zim CHIC | Biotech Hunter | Biotech Hunter